- Reported JV investments can understate exposure from shareholder loans, guarantees, unfunded commitments, and other commercial arrangements (e.g., leases, take or pay offtake).
- Across 50 companies, the authors identify $612 billion in total JV exposure against $351 billion in reported investments.
- Analysts should assess the full obligations, potential cash calls, and partners’ ability to fund their share.
Joint ventures have become the load-bearing walls of the industrial economy.
In mining, over three-quarters of copper and nearly two-thirds of lithium production come from JVs; in oil and gas, roughly half the output at majors like Shell, ExxonMobil, and Chevron comes from ventures they do not operate.
Beyond natural resources, JVs now account for more than half of new AI-infrastructure partnerships and most new battery plants. Steep costs, a desire to spread the risk, and a decade of cheap money fueled the growth. New JV formation has risen nearly 550% since 2020.
Higher rates have repriced the debt these structures run on, and the weakest partners are running out of room. The exposures built in the easy years now face their first real stress test.
Portfolio managers and equity and financial analysts, need to look beyond the reported “Investment in JV” line in company filings. That line tells the analyst very little – only the book value the company carries for the JV—and misses the venture’s overall economic exposure to the company.
A firm that moves a $10 billion investment into a JV reports lower leverage, a higher return on capital, and a leaner asset base — while a loan it makes to the venture counts as an asset, not debt.
The items that actually put capital at risk, shareholder loans, debt guarantees, and long-term purchase commitments, determine how much is on the line if the venture struggles.
